ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 199 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $393,800 | -70.1% | 44,598 | -74.1% | 0.01% | -79.0% |
| Q4 2022 | $1,317,029 | +339.0% | 172,386 | +308.9% | 0.06% | +520.0% |
| Q3 2022 | $300,000 | -18.7% | 42,161 | -6.2% | 0.01% | -9.1% |
| Q2 2022 | $369,000 | -38.1% | 44,935 | +4.6% | 0.01% | -8.3% |
| Q1 2022 | $596,000 | -50.7% | 42,947 | +0.7% | 0.01% | -50.0% |
| Q4 2021 | $1,208,000 | -27.6% | 42,654 | -17.0% | 0.02% | -22.6% |
| Q3 2021 | $1,668,000 | -4.5% | 51,399 | +24.2% | 0.03% | +10.7% |
| Q2 2021 | $1,746,000 | +8.7% | 41,385 | -3.1% | 0.03% | -3.4% |
| Q1 2021 | $1,606,000 | -42.5% | 42,727 | -9.1% | 0.03% | -52.5% |
| Q4 2020 | $2,792,000 | +17.2% | 47,008 | -5.3% | 0.06% | -19.7% |
| Q3 2020 | $2,383,000 | +188.1% | 49,614 | +176.3% | 0.08% | +162.1% |
| Q2 2020 | $827,000 | – | 17,955 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |